592508-12-8

Basic information

• Product Name: Benzene, 1-bromo-2-[(methylthio)methoxy]-
• CAS NO: 592508-12-8
• Molecular Formula: C8H9BrOS
• Molecular Weight: 233.129
• Mol File: 592508-12-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzene, 1-bromo-2-[(methylthio)methoxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-bromo-2-[(methylthio)methoxy]-(592508-12-8)
• EPA Substance Registry System: Benzene, 1-bromo-2-[(methylthio)methoxy]-(592508-12-8)

Safety Data

• Hazardous Substances Data: 592508-12-8(Hazardous Substances Data)

Upstream product

• 74-88-4 methyl iodide 

Downstream Products

• 90-43-7 2-Phenylphenol 
• 1443418-26-5 C₁₅H₁₅BrO₂ 
• 1443418-25-4 C₁₃H₁₀BrFO₂ 
• 1443418-24-3 C₁₄H₁₃BrO₃ 
• 220-11-1 dibenzo[d,f][1,3]dioxepin 
• 1806-29-7 2,2'-dihydroxybiphenyl 
• 1443418-23-2 C₁₃H₁₁BrO₂ 
• 1192110-10-3 C₁₃H₁₀Br₂O₂ 
• 1443418-31-2 C₁₅H₁₃BrO₄ 
• 592508-14-0 (R)-2-[(6aS,11aR)-(7,8,9,10,11,11a-Hexahydro-5-oxa-11-aza-cyclohepta[a]naphthalen-6a-yl)amino]-2-phenyl-ethanol 
• 500131-66-8 (3R,5S,8aR)-5-[(2-bromophenoxy)methyl]-3-phenyl-hexahydro-5H-[1,3]oxazolo[3,2-a]pyridine-5-carbonitrile 
• 500131-67-9 (2R)-2-[(1S,12S)-10-oxa-2,16-diazatetracyclo[10.3.1.0^3,12.0^4,9]hexadeca-2,4⁽⁹⁾,5,7-tetraen-16-yl]-2-phenyl-1-ethanol 
• 500131-69-1 (3S,8aR,14bS)-3-phenyl-2,3,5,6,7,8-hexahydro-14bH-chromeno[4,3-b]pyrido[2,1-c][1,4]oxazin-14b-ol 
• 500131-68-0 (3S,8aR,14bS)-3-phenyl-2,3,5,6,7,8-hexahydro-14bH-chromeno[4,3-b]pyrido[2,1-c][1,4]oxazin-14b-amine 

Relevant articles and documents

N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS

A compound of formula I wherein: R is alkyl; R1 is optionally substituted phenyl 2-oxo-tetrahydro-1(2H)-pyrimidinyl, or 2-oxo-1-piperidinyl; R2 is hydrogen, alkoxy, alkanoyloxy, alkoxycarbonyl, alkanoylamino, acyl, alkyl, carbamoyl, N-alkylcarbamoyl, N,N-dialkylcarbamoyl where the alkyl groups are the same or different, hydroxy, thioacyl, thiocarbamoyl, N-alkylthiocarbamoyl, or N,N-dialkylthiocarbamoyl where the alkyl groups are the same or different. X1 and X2 are independently hydrogen or halo, provided that at least one of X1 or X2 is halo; and R3, R4, R5 and R6 are independently hydrogen, cyano, nitro, trifluoromethoxy, trifluoromethyl, or alkylsulfonyl are antagonists of at least one tachykinin receptor and are useful in the treatment of depression, anxiety, asthma, pain, inflammation, urinary incontinence and other disease conditions. Process for their preparation are described, as are compositions containing them and their use.